Remdesivir approved by the FDA
The US Food and Drug Administration (FDA) on Thursday (October 22nd) announced the antiviral drug Remdesivir as the first and only approved drug in the treatment of patients with Covid-19.
Remdesivir is produced for the first time in Iran by Ronak Daru Pharmaceutical Company and is available to hospitals and medical centers.
Remdesivir is recommended for the treatment of adults and children (people 12 years of age and older weighing at least 40 kg) with covid-19 who require hospitalization.
It should be used in hospitals or other treatment centers that are able to provide intensive care to patients.
Many patients with this disease have mild symptoms and do not need hospital care.